The Standard care versus Celecoxib Outcome Trial (SCOT trial): A Large Streamlined Safety Study.
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2016
At a glance
- Drugs Celecoxib (Primary) ; Diclofenac; Ibuprofen; Meloxicam; Naproxen
- Indications Osteoarthritis; Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms SCOT; SCOTLSSS
- 07 Jan 2016 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 06 Jul 2015 Planned End Date changed from 1 Feb 2015 to 1 Jul 2015 as per ClinicalTrials.gov record.
- 06 Jul 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Jul 2015 as per ClinicalTrials.gov record.